Ten simple rules for establishing a drug discovery lab in resource-limited settings
by Ryman Shoko, Chipampe Lombe, Tsungai Faith Manyadza, Sithulisiwe Ngwenya, Peter Mubanga Cheuka, Grace Mugumbate
Search fresh public links, source activity, and post angles for Drug Discovery.
Fresh curated links around Drug Discovery are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
by Ryman Shoko, Chipampe Lombe, Tsungai Faith Manyadza, Sithulisiwe Ngwenya, Peter Mubanga Cheuka, Grace Mugumbate
Organoids, spheroids, and other complex cellular models allow scientists to recreate aspects of tissue structure and function in the laboratory. These systems now play a central ro...
The tech giant’s new AI platform aims to make drug discovery faster and cleaner.
Despite remarkable progress in medical science, the prognosis for most patients diagnosed with advanced-stage cancers remains bleak. The challenge lies not only in the complexity o...
The latest volume of SLAS Discovery ushers in a transformative wave in drug discovery methodologies through its spotlight on pioneering research that leverages advanced imaging tec...
When Kelly Chibale left North America to take a job in Africa, a well-meaning mentor asked him if he was sure he'd want to leave the world-class facilities and research opportuniti...
In a groundbreaking leap for neurodegenerative disease therapeutics, researchers have unveiled DeepDrugDiscovery, an innovative AI-driven screening platform designed to identify no...
David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...
New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new "receptor diversion" microscopy-based screening system for targeting receptors long considered diffi...
Researchers at the University of Pennsylvania developed ApexGO, an AI-powered system that optimizes antimicrobial peptides, rapidly improving antibiotic candidates and identifying...
CDD and Lilly say their agreement paves the way for the planned integration of Lilly TuneLab in both the core and AI modules within CDD Vault for biotech companies that opt into th...
In a groundbreaking advancement that stands to transform the landscape of antimicrobial drug discovery, researchers at McMaster University have engineered a revolutionary generativ...
“Outliers are what you're going for,” Model Medicines CEO Daniel Haders, Ph.D., told Fierce to explain the company's AI-driven drug development strategy.
Large-scale screening campaigns are essential as they provide the dense, reliable, datasets required to train AI models and extract meaningful insights for sequence and chemistry p...
China’s faster, more efficient model is forcing U.S. competitors to rethink how they innovate.
Researchers used two AI systems, Robin and Co-Scientist, to collapse the timeline from idea to drug candidate. The post AI Lab Partners Are Rewiring the Hunt for New Drugs appeared...
The bottleneck isn’t discovery anymore. It’s execution. In peptides, programs are running into challenges around analytical complexity, scaleup, and the availability of key raw mat...
From designing drugs with a text prompt to XR-guided experiments, agentic AI is transforming the modern lab. NVIDIA GTC brought together life science leaders to discuss how these a...
Learn how early coordination across functions, phases and partners can reduce risk and accelerate drug development.
The need for medical treatments for rare diseases such as Leigh syndrome is high. However, low patient numbers make research into treatments difficult. Together with a team from th...
AWS's new AI platform grants researchers direct access to a broad library of biological foundation models for lab-in-the-loop drug discovery and brings enterprise-grade scale, priv...
A groundbreaking discovery from the Buck Institute for Research on Aging may soon rewrite the medical landscape for patients suffering from Primary Hyperoxaluria Type 2 (PH2), an a...
Formerly known as Verge Genomics, the new Verge Labs will help pharma and biotech partners match potential brain drugs to patients who best benefit from them.
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.